NCT01140347 · Interventional trial
A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib
Overall registry status Completed
Phase 3
Conditions Hepatocellular Carcinoma
Delaware Valley sites
- ImClone Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory